Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study

Fig. 1

Overall survival curves of all patients who received palliative chemotherapy according to venous thromboembolism occurrence. a Median OS of patents with early VTE was 3.7 months (95% CI, 2.135–5.265); that of patients with late VTE or without VTE was 6.4 months (95% CI, 5.522–7.278, p = 0.005). bMedian OS of patents with early VTE was 3.7 months (95% CI, 2.135–5.265); that of patients with late VTE was 9.8 months (95% CI, 3.836–15.764) and that of patients without VTE was 6.3 months (95% CI, 5.493–7.107, p = 0.008).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us